Abstract
Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PL5.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have